AJMC September 4, 2024
Pearl Steinzor

According to some reports, the draft rule imposes strict limitations on telehealth prescriptions even as advocates push for extension of current flexibilities.

The Drug Enforcement Administration (DEA) is nearing the final stages of its rulemaking process for prescribing controlled substances via telehealth, but leaked details reveal a more restrictive approach than anticipated.1

While advocates are once again lobbying the White House and Congress to extend a waiver on the use of telemedicine to prescribe medications, leaked details suggest this prescribing route will be limited, according to anonymous sources speaking to Fierce Healthcare and Politico.1,2

The telehealth prescribing flexibility rule has been used since 2020 to prescribe medications for conditions such as substance abuse disorder and attention deficit disorder. Last year,...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Digital Health, Govt Agencies, Mental Health, Patient / Consumer, Provider, Technology, Telehealth
Telehealth gets short extension, physician pay is cut in spending bill
Amazon One Medical: the beginning of a text-based TeleHealth revolution?
Congress Extends Hospice Telehealth Flexibilities
Telehealth Pathway for IBD Surgery Expanded Access to Care in Small Study
Senior Living Operators, Experts Urge Extension of Medicare Telehealth, Post-Acute Waivers

Share This Article